Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation

Stopped Secondary to safety concerns plus change in Campath® (alemtuzumab) availability.

Conditions

• Kidney Transplantation
• Renal Transplantation

Interventions

• DRUG: Alemtuzumab
• DRUG: MMF
• BIOLOGICAL: Basiliximab
• DRUG: Short-term Tac
• DRUG: tacrolimus
• BIOLOGICAL: Belatacept
• DRUG: methylprednisolone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

• [object Object]